These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23200236)

  • 21. The Role of
    Fukumoto K; Fukui T; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Sugiyama T; Kato K; Yokoi K
    World J Surg; 2017 Jul; 41(7):1828-1833. PubMed ID: 28265732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
    Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
    Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral metabolic heterogeneity by
    Chao F; Wang R; Han X; Huang W; Wang R; Yu Y; Lin X; Yuan P; Yang M; Gao J
    Thorac Cancer; 2024 Jun; 15(18):1437-1445. PubMed ID: 38757212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of positron-emission tomography for predicting the World Health Organization grade of thymic epithelial tumors.
    Kanou T; Funaki S; Minami M; Ose N; Kimura T; Fukui E; Watabe T; Shintani Y
    Thorac Cancer; 2022 Jun; 13(11):1651-1656. PubMed ID: 35460177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
    Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
    Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (18)Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker.
    Bertolaccini L; Viti A; Lanzi E; Fortunato M; Chauvie S; Bianchi A; Terzi A
    Gen Thorac Cardiovasc Surg; 2014 Apr; 62(4):228-33. PubMed ID: 24477745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
    Sung YM; Lee KS; Kim BT; Choi JY; Shim YM; Yi CA
    J Nucl Med; 2006 Oct; 47(10):1628-34. PubMed ID: 17015898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of [
    Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A
    Cancer Biother Radiopharm; 2024 Jun; 39(5):373-380. PubMed ID: 38484307
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
    Um SW; Kim H; Koh WJ; Suh GY; Chung MP; Kwon OJ; Choi JY; Han J; Lee KS; Kim J
    J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
    Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A
    Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of FDG-PET in the diagnosis of thymic epithelial tumors.
    Otsuka H
    J Med Invest; 2012; 59(3-4):225-34. PubMed ID: 23037192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of FDG uptake in early stage non-small cell lung cancer.
    Hanin FX; Lonneux M; Cornet J; Noirhomme P; Coulon C; Distexhe J; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of
    Akamine T; Nakagawa K; Ito K; Watanabe H; Yotsukura M; Yoshida Y; Yatabe Y; Kusumoto M; Watanabe SI
    Ann Surg Oncol; 2024 Jan; 31(1):192-200. PubMed ID: 37743455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
    Murakami S; Saito H; Sakuma Y; Mizutani Y; Ishikawa Y; Kondou T; Oshita F; Yokose T; Kameda Y; Suga Y; Ito H; Tsuboi M; Nakayama H; Noda K; Yamada K
    Eur J Radiol; 2010 Aug; 75(2):e62-6. PubMed ID: 20005653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.